Self-driving laboratories: how AI is reshaping the life science workplace
As life sciences move toward autonomous research, the laboratory is being redesigned around a shift in how scientists work, at a time when AI and robotics are taking over the market
The laboratory of the future? Well, it may look less like a room full of white-coat donned scientists and more akin to a connected system of automated robots. Life-sciences technology group Danaher just announced plans to launch its first AI-powered autonomous laboratory, designed to accelerate the development of antibodies and molecular tools. Based at Abcam – its Cambridge-based life science business – the facility will bring together AI, robotics and tech from across Danaher’s portfolio. The laboratory is expected to operate at scale by early 2027, with Danaher projecting that their new system, intertwined with AI, could dramatically accelerate the discovery of certain molecular tools, reducing discovery time by up to eightfold.
Through connecting AI models and physical laboratory equipment, the initiative points toward a model of scientific work where researchers define the questions, but automated systems conduct experiments, analyse results and use evidence to inform the next steps. However, for the people designing, building and managing the industry’s environments, a fundamental question is posed: if the process of research changes, how much must the workplace change with it?
An evolution for research
Autonomous laboratories, sometimes called self-driving labs, combine robotics, sensors, automated instruments and computational systems to create feedback loops between experimentation and analysis. Rather than waiting for a scientist to interpret one result at a time before setting up the next experiment, a connected system could use evidence to guide subsequent testing within defined parameters.
Earlier this year, Nature reported on research systems that were capable of utilising teams of AI agents to develop hypotheses, propose experiments and analyse subsequent results. Although human expertise and independent validation will always remain essential, AI is positioned to take a more active role in the experimental process.
More recently, King’s College London launched King’s Autonomous Labs, supported by an initial £150,000 funding programme to help researchers test approaches combining AI, robotics and laboratory automation. The development aims to connect experimental platforms and technical expertise across the university; with the systems intended to extend what researchers can investigate, rather than replacing the need for them altogether.
Together, this evolution suggests how autonomous research is moving toward a broader question of infrastructure; and how to connect instruments computing, data and people into a larger functioning research ecosystem.
Rethinking the modern laboratory
The implications of this type of development are potentially substantial for the industry. The adoption of automated experiments could change the balance between conventional bench space, robotic workstations, instrument rooms, sample storage and computer facilities. It also requires a complete restructuring of equipment access, maintenance, power supply, cooling, network resilience and environmental monitoring.
Within the human-centric dimension, scientists may spend less time performing repetitive procedures and more time designing experiments, interpreting results and working across disciplines. Inherently, this could increase the importance of creating spaces for collaboration, data analysis and interdisciplinary problem-solving.
However, it’s premature to assume automation may mean smaller laboratories. Faster experimentation could increase the volume of researcht; creating a grater demand for instruments, sample handling and all supporting infrastructure to process more material. The emerging model converges as one which brings together people, technology and physical equipment in an evolving space.
A market in transition
The transition comes at a complicated time for the UK life-science property market. CBRE’s UK Real Estate Market Outlook 2026 estimates that venture capital investment in UK life sciences reached £3.4 billion in 2025, down 12% year-on-year. Nevertheless, the report does identify the opportunities found in AI-driven drug discovery, synthetic biology and alternate research-intensive sectors where occupiers require more flexible working environments.
Specialist laboratories are however expensive to build and their technical specification makes them difficult to repurpose if demand changes. Developments designed around traditional wet-lab requirements may also not automatically suit the needs of the emerging medley between biology, AI and robotics. The opportunity may lie in more adaptable research environments, incorporating infrastructure than can accommodate to different combinations of laboratory work.
Designing for change
The wider investment picture reinforces that trajectory of where things are headed. October 2026 saw Reuters report a $1.8 billion initiative involving Biohub, US government bodies and tech companies including Google and Meta, to build biological datasets in order to facilitate AI training. The Virtual Biology Initiative aims to improve researchers’ ability to predict how cells respond to different variable conditions. The move illustrates a growing connection between experimental science, data and computational infrastructure.
The self-driving laboratory is not yet a universal blueprint for scientific workplaces, but the direction has been clearly highlighted. AI is becoming a part of the physical process of discovery. For life sciences, the challenge may lie in building for that change without betting on one singular vision for the future. And, the most resilient research workplaces may be designed around the ability to accommodate to tomorrow’s way of working.
